Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Cortesi

Showing results (121-130 of 181) with videos related to

Pageof 19
Sort By:
Breast (Edinburgh, Scotland)|May 6, 2008
Breast screening: axillary lymph node status of interval cancers by interval yearLauro Bucchi, Donella Puliti, Alessandra Ravaioli, et al.
Oncotargets and Therapy|May 23, 2019
Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future?Marina Elena Cazzaniga, Laura Biganzoli, Laura Cortesi, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 26, 2024
Fenretinide in Young Women at Genetic or Familial Risk of Breast Cancer: A Placebo-Controlled Biomarker TrialValentina Aristarco, Davide Serrano, Patrick Maisonneuve, et al.
Current Oncology (Toronto, Ont.)|December 24, 2025
<i>DonnaRosa</i> Project: Exploring Informal Communication Practices Among Breast Cancer SpecialistsAntonella Ferro, Flavia Atzori, Catia Angiolini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2015
Triple-Negative versus Non-Triple-Negative Breast Cancers in High-Risk Women: Phenotype Features and Survival from the HIBCRIT-1 MRI-Including Screening StudyFranca Podo, Filippo Santoro, Giovanni Di Leo, et al.
BMC Cancer|January 23, 2025
Integrating BRCA testing into routine prostate cancer care: a multidisciplinary approach by SIUrO and other Italian Scientific SocietiesGiulia Mammone, Simona Borghesi, Nicolò Borsellino, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2023
Platinum-based chemotherapy and PARP inhibitors for patients with a germline BRCA pathogenic variant and advanced breast cancer (LATER-BC): retrospective multicentric analysis of post-progression treatmentsCarmine Valenza, Dario Trapani, Sara Gandini, et al.
European Journal of Cancer (Oxford, England : 1990)|March 25, 2008
Evaluation of service mammography screening impact in Italy. The contribution of hazard analysisEugenio Paci, Enzo Coviello, Guido Miccinesi, et al.
Diagnostics (Basel, Switzerland)|April 3, 2021
The Prognostic and Predictive Role of Somatic <i>BRCA</i> Mutations in Ovarian Cancer: Results from a Multicenter Cohort StudyAngela Toss, Claudia Piombino, Elena Tenedini, et al.
Breast (Edinburgh, Scotland)|November 15, 2022
PARP-inhibitors for BRCA1/2-related advanced HER2-negative breast cancer: A meta-analysis and GRADE recommendations by the Italian Association of Medical OncologyFederica Miglietta, Michela Cinquini, Maria Vittoria Dieci, et al.
Pageof 19

Showing results (121-130 of 181) with videos related to

Sort By:
Pageof 19
Breast (Edinburgh, Scotland)|May 6, 2008
Breast screening: axillary lymph node status of interval cancers by interval yearLauro Bucchi, Donella Puliti, Alessandra Ravaioli, et al.
Oncotargets and Therapy|May 23, 2019
Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future?Marina Elena Cazzaniga, Laura Biganzoli, Laura Cortesi, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 26, 2024
Fenretinide in Young Women at Genetic or Familial Risk of Breast Cancer: A Placebo-Controlled Biomarker TrialValentina Aristarco, Davide Serrano, Patrick Maisonneuve, et al.
Current Oncology (Toronto, Ont.)|December 24, 2025
<i>DonnaRosa</i> Project: Exploring Informal Communication Practices Among Breast Cancer SpecialistsAntonella Ferro, Flavia Atzori, Catia Angiolini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2015
Triple-Negative versus Non-Triple-Negative Breast Cancers in High-Risk Women: Phenotype Features and Survival from the HIBCRIT-1 MRI-Including Screening StudyFranca Podo, Filippo Santoro, Giovanni Di Leo, et al.
BMC Cancer|January 23, 2025
Integrating BRCA testing into routine prostate cancer care: a multidisciplinary approach by SIUrO and other Italian Scientific SocietiesGiulia Mammone, Simona Borghesi, Nicolò Borsellino, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2023
Platinum-based chemotherapy and PARP inhibitors for patients with a germline BRCA pathogenic variant and advanced breast cancer (LATER-BC): retrospective multicentric analysis of post-progression treatmentsCarmine Valenza, Dario Trapani, Sara Gandini, et al.
European Journal of Cancer (Oxford, England : 1990)|March 25, 2008
Evaluation of service mammography screening impact in Italy. The contribution of hazard analysisEugenio Paci, Enzo Coviello, Guido Miccinesi, et al.
Diagnostics (Basel, Switzerland)|April 3, 2021
The Prognostic and Predictive Role of Somatic <i>BRCA</i> Mutations in Ovarian Cancer: Results from a Multicenter Cohort StudyAngela Toss, Claudia Piombino, Elena Tenedini, et al.
Breast (Edinburgh, Scotland)|November 15, 2022
PARP-inhibitors for BRCA1/2-related advanced HER2-negative breast cancer: A meta-analysis and GRADE recommendations by the Italian Association of Medical OncologyFederica Miglietta, Michela Cinquini, Maria Vittoria Dieci, et al.
Pageof 19